Polpharma to buy 33% stake in Bioton

08/19/2008 | Portfolio.hu (Hungary)

Prokom Investments said it will sell its 33.3% stake in insulin manufacturer Bioton to generic-drug maker Polpharma for about $198 million, with additional milestone payments. Polpharma owner Jerzy Starak said the deal, set to be completed within a month, is a strategic move to biotech products, which he called the future of the pharmaceutical industry.

View Full Article in:

Portfolio.hu (Hungary)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR